Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
AOD-9604 and BPC-157 in Combination Research AOD-9604 and BPC-157 are frequently mentioned together in peptide research discussions because theyre studied in adjacent but distinct areas AOD-9604 in fat metabolism, BPC-157 in tissue repair and gastrointestinal research rather than because of any overlapping mechanism
Once your dose is ready, safely dispose of the drawing needle and attach your injecting needle (usually blue or green)
RGN-352 is RegeneRx Biopharmaceuticals' injectable Thymosin Beta-4 formulation developed for cardiac repair and systemic tissue damage
Ideally, youd want labs done at the beginning and again with each dose increase, or at least every 36 months, to make sure the medication is working safely and not causing unwanted side effects
